Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
First Claim
1. A composition comprising a selectively cleavable linker for polymer synthesis comprising a linker group having first and second ends, wherein said first end comprises a substrate attaching group and wherein said second end comprises a polymer attaching group, wherein said polymer attaching group is covalently linked to an anchor moiety.
3 Assignments
0 Petitions
Accused Products
Abstract
A method of modulation of synthesis capacity on and cleavage properties of synthetic oligomers from solid support is described. The method utilizes linker molecules attached to a solid surface and co-coupling agents that have similar reactivities to the coupling compounds with the surface functional groups. The preferred linker molecules provide an increased density of polymers and more resistance to cleavage from the support surface. The method is particularly useful for synthesis of oligonucleotides, oligonucleotides microarrays, peptides, and peptide microarrays. The stable linkers are also coupled to anchor molecules for synthesis of DNA oligonucleotides using on support purification, eliminating time-consuming chromatography and metal cation presence. Oligonucleotides thus obtained can be directly used for mass analysis, DNA amplification and ligation, hybridization, and many other applications.
117 Citations
35 Claims
- 1. A composition comprising a selectively cleavable linker for polymer synthesis comprising a linker group having first and second ends, wherein said first end comprises a substrate attaching group and wherein said second end comprises a polymer attaching group, wherein said polymer attaching group is covalently linked to an anchor moiety.
-
15. A compound of the structure:
Rs-L-Rp wherein Rs is a substrate attaching group, Rp is a polymer attaching group, and L is the linker. - View Dependent Claims (16, 17)
-
18. A compound having the following structure:
S—
R1—
R2—
R3—
R4wherein S is a substrate, R1 is a linker group, R2 is a polymer, R3 is an anchor, and R4 is either nothing or a polymer, where R2 and R4 do not need to be the same. - View Dependent Claims (19)
-
20. A compound of the structure:
-
Rs-L-Rp wherein Rs is a substrate attaching group, Rp is a polymer attaching group, and L is the linker. - View Dependent Claims (21, 22, 23, 24)
-
23. The compound of claim 22, wherein B is uridine.
-
24. The compound of claim 20, wherein said polymer is an oligonucleotide.
-
-
25. A method for synthesizing oligonucleotides comprising:
-
a) providing i) a substrate;
ii) a plurality of stable linkers;
iii) a plurality of anchor moieties; and
iv) nucleotide monomers;
b) derivitizing said substrate with said plurality of stable linkers;
c) attaching said anchor moieties to said stable linkers; and
d) synthesizing a oligonucleotide on said plurality of anchor moieties from said monomers.
-
-
26. A method for synthesizing oligonucleotides comprising:
-
a) providing i) a substrate;
ii) a plurality of stable linkers;
iii) a plurality of anchor moieties; and
iv) nucleotide monomers;
b) derivitizing said substrate with said plurality of stable linkers;
c) synthesizing a oligonucleotide on said plurality of anchor moieties from said monomers; and
d) attaching said anchor moieties to said polymers; and
e) synthesizing a oligonucleotide on said plurality of anchor moieties from said monomers.
-
-
27. A method for controlling the number of oligonucleotides synthesized at a predetermined site on a substrate comprising:
-
a) Providing i) a substrate;
ii) a plurality of stable linkers;
iii) a plurality of anchor moieties;
iv) nucleotide monomers; and
v) co-coupling agents;
b) derivitizing said substrate with said plurality of stable linkers;
c) attaching said anchor moieties to said stable linkers; and
d) synthesizing a oligonucleotide on said plurality of anchor moieties from said monomers and co-coupling agents
-
-
28. A method of providing purified oligonucleotides comprising:
-
a) providing;
i) a substrate comprising oligonucleotides attached to a substrate via an anchor moiety attached to a stable linker group;
ii) a deprotecting solution; and
iii) and a wash solution;
b) deprotecting said oligonucleotides with said deprotecting solution, c) washing said oligonucleotides attached to a substrate with said wash solution, d) cleaving said oligonucleotides at said anchor group to provide purified oligonucleotides, wherein said purified oligonucleotides are characterized by the substantial absence of small molecules formed during deprotection step.
-
-
29. A method of providing purified oligonucleotides comprising:
-
a) providing;
i) a substrate comprising oligonucleotides attached to a substrate via an anchor moiety attached to an oligonucleotide attached a stable linker group;
ii) a deprotecting solution; and
iii) a wash solution;
b) deprotecting said oligonucleotides with said deprotecting solution, c) washing said oligonucleotides attached to a substrate with said wash solution, d) cleaving said oligonucleotides at said anchor group to provide purified oligonucleotides, wherein said purified oligonucleotides are characterized by the substantial absence of small molecules formed during deprotection step.
-
-
30. A method of providing purified oligonucleotides for use of enzymatic reactions:
-
a) providing;
i) oligonucleotides obtained from solid phase synthesis and directly purified while the oligonucleotides attached on the support; and
ii) oligonucleotides having 5′
-OH or 5′
-phosphate, and 3′
-OH at the end of the sequence;
b) mixing oligonucleotides with a DNA polymerase and DNA template strands having a complementary sequence to the oligonucleotide at the 3′
-end in a DNA polymerization buffer; and
c) recovering copies of complementary DNA strands in the duplex with the template strand.
-
-
31. A method of providing purified oligonucleotides for use of enzymatic reactions:
-
a) providing;
i) oligonucleotides obtained from solid phase synthesis and directly purified while the oligonucleotides attached on the support; and
ii) oligonucleotides having 5′
-OH or 5′
-phosphate, and 3′
-OH at the end of the sequence;
b) mixing oligonucleotides with a DNA polymerase and DNA template strands having a complementary sequence to the oligonucleotide at the 3′
-end in a PCR buffer; and
c) recovering amplified copies of complementary DNA strands in the duplex with the template strand.
-
-
32. A method of providing purified oligonucleotides for use of enzymatic reactions:
-
a) providing;
i) oligonucleotides obtained from solid phase synthesis and directly purified while the oligonucleotides attached on the support; and
ii) oligonucleotides having 5′
-phosphate and 3′
-OH at the end of the sequence;
iii) oligonucleotides which in part form duplexes with dangling ends on both 3′
- and 5′
-end;
d) mixing oligonucleotides with a DNA ligase in a ligation buffer; and
e) recovering ligated DNA strands.
-
-
33. A method of providing purified oligonucleotides for use of enzymatic reactions:
-
a) providing;
i) oligonucleotides obtained from solid phase synthesis and directly purified while the oligonucleotides attached on the support; and
ii) oligonucleotides having 5′
-OH and 3′
-OH at the end of the sequence;
iii) oligonucleotides which in part form duplexes with dangling ends on both 3′
- and 5′
-end;
b) mixing oligonucleotides with a 5′
-kinase in a kinase bufferc) recovering oligonucleotides having 5′
-phosphate and 3′
-OH at the end of the sequenced) mixing oligonucleotides with a DNA ligase in a ligation buffer; and
e) recovering ligated DNA strands.
-
- 34. A compound having the following structure:
Specification